Italy· 049442015
ONTOZRY*14 cpr rivestite 25 mg + 14 cpr rivestite 12,5 mg
A cenobamate product containing cenobamato, registered in Italy by ANGELINI PHARMA ITALIA SpA, on the national reimbursement list. The same ATC class is registered in 15 of our 19 countries.
Checked against the register on
Informational only — not a medical device.
Where it is registered
Cenobamate is registered in 15 of 19 countries.
Countries holding a registration under ATC N03AX25 (cenobamate), each read from that country’s own register.
- This record: Italy
- 10 of them publish a price we can compare per daily dose
Cenobamate · ATC N03AX25
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of cenobamate costs, country by country.
Normalised to the WHO defined daily dose (0.2 g), the median price runs from $4.11 in France to $21.72 in Switzerland — a ×5.3 gap.
- Italy: $19.89 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Cenobamate · price per daily dose (0.2 g)
USD · FX 28 Sept 2026
- CH Switzerland$21.72
- IT Italy$19.89
- CZ Czechia$4.12
- FR France$4.11
The record
At a glance
- Active substance
- Cenobamato
- Manufacturer
- ANGELINI PHARMA ITALIA SpA
- Country
- Italy (IT)
- ATC code
- N03AX25
- ATC class
- Cenobamate
- Defined daily dose
- 0.2 g, O
- Reimbursed
- Yes
- Last checked
- June 4, 2026
Packs & prices · 1
1 priced- aic049442015ONTOZRY*14 cpr rivestite 25 mg + 14 cpr rivestite 12,5 mgEUR 244.56
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
273 interactions on record for cenobamate.
Graded by severity as the source publishes them — 29 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Cenobamate · interactions on record
273 records
- 29 severe
- 237 moderate
- 7 minor
Most severe, free to view
- DeflazacortH02AB13severe
- BosutinibL01EA04severe
- EncorafenibL01EC03severe
- BrigatinibL01ED04severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Cenobamate in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwitzerlandOntozry 100 mg, FilmtablettenAngelini Pharma S.p.A., Rom, Zweigniederlassung Zug
- CzechiaONTOZRYAngelini Pharma S.p.A, Rome
- United StatesXcopriSK Life Science, Inc.
- FinlandOntozryAngelini Pharma S.p.A
- United KingdomOntozry 100mg tabletsAngelini Pharma UK-I Ltd
- NorwayOntozryAngelini Pharma S.p.A.
- SpainONTOZRY 100 mg COMPRIMIDOS RECUBIERTOS CON PELICULAAngelini Pharma Italia Aziende Chimiche Riunite Angelini Francesc O A.C.R.A.F. S.P.A. Enunciabile An
- CanadaXCOPRIENDO OPERATIONS LTD.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Ontozry
- Liechtenstein · Ontozry
- Norway · Ontozry
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f8894296-53d9-408a-9597-dbc6a2cf3422 GET /v1/drugs/f8894296-53d9-408a-9597-dbc6a2cf3422?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"price": 244.56,
"source": "aifa",
"currency": "EUR",
"strength": "CENOBAMATO 25MG 14 UNITA' + 12,5MG 14 UNITA' USO ORALE",
"substance": "Cenobamato",
"equivalence_group": "LYR",
"transparency_flag": null
}See everything about cenobamate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.